Skip to main content

TSX Global Gold Index(TTGD)
INDEX/TSX

Today's Change
Real-Time Last Update

Interesting Development Prior To Closing Bell

AllPennyStocks.com - Tue Sep 26, 2023

Two different dually-listed Uranium companies are finding success on Tuesday while the broader equities markets are currently taking a big hit. We found it interesting that both of these stocks were outperforming the market so much, especially since neither of them have major announcements or press releases today.

Shares of GoviEx Uranium Inc. (TSXV:GXU)(OTCQX:GVXXF) are rallying strongly into the close, with shares on the Canadian side trading around $0.175/share (+2.94%) and those trading OTC are currently around $0.1295/share (+1.95%).

Shares of the second company, Purepoint Uranium Group Inc. (TSXV:PTU)(OTCQB:PTUUF) are trading at $0.06/share (+9.09%) on the Canadian side while trading at $0.0042/share (+12.00%) OTC.

It would be worth expanding our focus on this sector should Uranium stocks continue to outperform!

Company Backgrounds:

GoviEx Uranium Inc is a Canada-based company involved in the industrial metals and mining business sector. It is focused on the evaluation and development of uranium properties located in the Republic of Niger. The asset portfolio of the company includes uranium development projects, including the Madaouela projectin Niger, Mutanga project in Zambia, and Falea in Mali.

Purepoint Uranium Group Inc is a resource company engaged in the acquisition, exploration, and development of properties to produce uranium. Its mineral properties are all located at the Athabasca Basin, Northern Saskatchewan, Canada. The group's properties include Hook Lake, Red Willow, Turnor Lake, Henday Lake, and Umfreville Lake.

Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

More from The Globe